Epicardial Versus Septal Collateral Channels in Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Safety and Long-Term Outcomes
Journal of Cardiovascular Development and Disease · 02.11.2026 · 13 (11) · 561
DOI: 10.3390/jcdd13110561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 02.11.2026. Verfasst von Xingjie Huang und 8 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Natural Science Foundation Program, Henan Provincial Medical Science and Technology Talents Overseas Training Program, Henan Provincial Medical Science and Technology Key Program.
Abstract (Originalsprache)
Background
Septal collateral channels (CCs) are generally preferred for retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) because epicardial CC injury may result in hemopericardium and cardiac tamponade. However, comparative evidence on the procedural safety and long-term clinical outcomes of epicardial versus septal CC use remains limited.
Methods
We retrospectively analyzed 750 patients who underwent elective retrograde CTO PCI from January 2011 through April 2023. The primary procedural safety outcome was periprocedural pericardial effusion. The primary long-term outcome was major adverse cardiovascular events (MACEs), defined as all-cause death, nonfatal myocardial infarction, stroke, or unplanned revascularization. Multivariable logistic and Cox regression models were used to evaluate these outcomes.
Results
544 patients underwent retrograde CTO PCI through a septal CC and 206 through an epicardial CC. Pericardial effusion (7.3% vs. 1.7%; p < 0.001) and pericardiocentesis (5.3% vs. 1.1%; p = 0.001) were more frequent with epicardial CC use. CC wire crossing success (90.8% vs. 94.5%; p = 0.067), retrograde technical success (87.9% vs. 90.1%; p = 0.40), and overall recanalization success (90.3% vs. 91.0%; p = 0.80) did not differ significantly. Epicardial CC use was associated with higher odds of pericardial effusion (OR 5.60, 95% CI 2.26–14.70, p < 0.001). During a median follow-up of 1039 days, MACE occurred in 15.0% and 16.5% of the epicardial and septal CC groups, respectively (HR 1.10, 95% CI 0.71–1.70, p = 0.659).
Conclusions
Epicardial CC use was associated with more periprocedural pericardial effusion than septal CC use. No statistically significant differences in technical success or long-term MACE were detected; these findings do not establish equivalence and are subject to anatomical selection and residual confounding.
Förderung
- Henan Provincial Natural Science Foundation Program
- Henan Provincial Medical Science and Technology Talents Overseas Training Program
- Henan Provincial Medical Science and Technology Key Program
- Guangxi Clinical Key Specialty Construction Project
Zitieren
APA
Huang, X., Hu, D., Wan, Q., Huang, Y., Ma, D., Wang, F., Han, F., Huang, Z., & Wen, S. (2026). Epicardial Versus Septal Collateral Channels in Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Safety and Long-Term Outcomes. Journal of Cardiovascular Development and Disease, 13(11), 561. https://doi.org/10.3390/jcdd13110561
Vancouver
Huang X, Hu D, Wan Q, Huang Y, Ma D, Wang F, et al. Epicardial Versus Septal Collateral Channels in Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Safety and Long-Term Outcomes. Journal of Cardiovascular Development and Disease. 2026;13(11):561. doi:10.3390/jcdd13110561
BibTeX
@article{Huang2026,
author = {Huang, Xingjie and Hu, Dan and Wan, Qiheng and Huang, Yuqing and Ma, Dunliang and Wang, Feng and Han, Feihuang and Huang, Zehan and Wen, Song},
title = {Epicardial Versus Septal Collateral Channels in Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Safety and Long-Term Outcomes},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {11},
pages = {561},
doi = {10.3390/jcdd13110561}
}
EUVIMED